Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma

Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. Immunotherapy may be promising for the treatment of some patients with GBM; however, there is a need for noninvasive neuroimaging techniques to predict immunotherapeutic responses. The effectiveness of most immunother...

Descripción completa

Detalles Bibliográficos
Autores principales: Nisnboym, Michal, Vincze, Sarah R., Xiong, Zujian, Sneiderman, Chaim T., Raphael, Rebecca A., Li, Bo, Jaswal, Ambika P., Sever, ReidAnn E., Day, Kathryn E., LaToche, Joseph D., Foley, Lesley M., Karimi, Hanieh, Hitchens, T. Kevin, Agnihotri, Sameer, Hu, Baoli, Rajasundaram, Dhivyaa, Anderson, Carolyn J., Blumenthal, Deborah T., Pearce, Thomas M., Uttam, Shikhar, Nedrow, Jessie R., Panigrahy, Ashok, Pollack, Ian F., Lieberman, Frank S., Drappatz, Jan, Raphael, Itay, Edwards, Wilson B., Kohanbash, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324623/
https://www.ncbi.nlm.nih.gov/pubmed/37426447
http://dx.doi.org/10.1158/2767-9764.CRC-22-0434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324623/
https://www.ncbi.nlm.nih.gov/pubmed/37426447
http://dx.doi.org/10.1158/2767-9764.CRC-22-0434

Ejemplares similares